Daniel Grasseschi

Chemistry

Daniel Grasseschi is a surface chemist who studies ways to manipulate atomic bonds to create nanomaterials. Nanomaterials are materials with structures measured in nanometers, or billionths of a meter. They have unique properties that make them useful for various applications, including renewable energy, electronics, and medicine.

Grasseschi’s research is at the forefront of nanomaterials research, and his work has the potential to lead to new and innovative applications. For example, he is developing new methods for assembling nanomaterials one atom at a time. This could allow scientists to create nanomaterials with precise structures and properties that are impossible with current methods.

Grasseschi graduated from the University of São Paulo with a degree in chemistry and a doctorate in nanotechnology. He has held two postdoctoral positions, one at the Center for Advanced Research in Graphene, Nanomaterials and Nanotechnology (Mackgrafe) at Mackenzie Presbyterian University and the other at the Center of 2-Dimensional and Layered Materials at Pennsylvania State University. In 2018, he became an adjunct professor at the Chemistry Institute of the Federal University of Rio de Janeiro, where he also coordinates the Supernano Lab.

Outside of the lab, Grasseschi enjoys cycling and running on the beach to relax.

Open Calls

Science Call 4
Array
(
    [0] => WP_Post Object
        (
            [ID] => 13479
            [post_author] => 10
            [post_date] => 2023-07-24 18:43:23
            [post_date_gmt] => 2023-07-24 18:43:23
            [post_content] => This project aims to address cytokine release syndrome (CRS) in patients treated with CAR-T cells, which are used in cancer immunotherapy. The project proposes using nanomaterial-based biosensors, such as graphene or metallic nanoparticles, to detect the presence of IL-6 early and predict the occurrence of CRS, allowing for early treatment of toxic reactions. This approach aims to reduce severe clinical events, hospitalization time, and drug costs, benefiting patients’ health and reducing expenses for the public health system (SUS).
            [post_title] => Development of a predictive biosensor for Cytokine release syndrome
            [post_excerpt] => 
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => desenvolvimento-de-um-biossensor-para-predizer-a-sindrome-de-liberacao-de-citocinas-em-pacientes-oncologicos-tratados-por-celulas-car-t
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2026-02-12 19:17:42
            [post_modified_gmt] => 2026-02-12 19:17:42
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://serrapilheira.org/?post_type=projeto&p=13479
            [menu_order] => 0
            [post_type] => projeto
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

)

Projects

Development of a predictive biosensor for Cytokine release syndrome
Chemistry, Life Sciences

This project aims to address cytokine release syndrome (CRS) in patients treated with CAR-T cells, which are used in cancer immunotherapy. The project proposes using nanomaterial-based biosensors, such as graphene or metallic nanoparticles, to detect the presence of IL-6 early and predict the occurrence of CRS, allowing for early treatment of toxic reactions. This approach aims to reduce severe clinical events, hospitalization time, and drug costs, benefiting patients’ health and reducing expenses for the public health system (SUS).

Amount invested

Grant 2023: R$ 31.915,00
  • Topics
  • nanomaterials
  • surface chemistry